GO:0031013 troponin I binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031013 (troponin I binding) is a molecular function defined as binding to troponin I, the inhibitory subunit of the troponin complex.
• Troponin I binding underlies calcium-dependent regulation of striated muscle contraction by anchoring tropomyosin on actin in a relaxed state.
• Cardiac troponin I (TNNI3) also binds mitochondrial ATP synthase, revealing a noncanonical role in the post-ischemic heart.
• Troponin I interactions with troponin C, tropomyosin, actin, and calmodulin are experimentally dissectable by binding and computational assays.
• Antibody and peptide binding to cardiac troponin I is exploited in biosensor development for myocardial infarction diagnosis.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of troponin I binding interfaces.
Description
Troponin I binding (GO:0031013) is a molecular function that describes the selective interaction of a protein or peptide with troponin I, the inhibitory subunit of the troponin complex. This function is central to the calcium-dependent switch that controls striated muscle contraction and relaxation, because troponin I physically traps tropomyosin on actin in a low-energy relaxed state. The same binding interface is also engaged by noncanonical partners, including mitochondrial ATP synthase, expanding the biological reach of this GO term beyond the sarcomere. Researchers study troponin I binding to understand thin-filament regulation, to map disease-causing mutations, and to engineer diagnostic and therapeutic reagents. Because the interaction is conformationally dynamic, it is best interrogated with a combination of structural, biochemical, computational, and genetic approaches.
troponin I binding At A Glance
| GO ID | GO:0031013 |
|---|---|
| GO term | troponin I binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to troponin I, the inhibitory subunit of the troponin complex. |
| Major function | Mediates calcium-dependent regulation of striated muscle contraction by anchoring tropomyosin on actin in a relaxed state. |
| Representative binders | Troponin C, tropomyosin, actin, calmodulin, mitochondrial ATP synthase, and anti-troponin I antibodies. |
| Disease relevance | Cardiac troponin I is a gold-standard biomarker of myocardial infarction and a target of cardiomyopathy-linked mutations. |
| Research methods | Binding assays, computational docking, biosensor development, and CRISPR-based genetic models. |
What Is GO:0031013?
In our own words, GO:0031013 (troponin I binding) is the molecular function of physically and selectively associating with troponin I, the inhibitory subunit of the troponin complex. It captures any protein, peptide, or antibody that recognizes troponin I, whether the partner is a sarcomeric component such as troponin C or tropomyosin, a noncanonical target such as mitochondrial ATP synthase, or an engineered binder used in diagnostics.
Why Is troponin I binding Important in Cell Biology?
Troponin I binding is important because it is the molecular event that converts a calcium signal into a mechanical output in cardiac and skeletal muscle, and because its dysregulation or mutation is directly linked to human disease. The interaction is also a validated diagnostic axis: cardiac troponin I is released after myocardial injury, and engineered binders that recognize it are the basis of rapid biosensors for myocardial infarction. More recently, cardiac troponin I was shown to bind mitochondrial ATP synthase and inhibit it, giving troponin I binding a noncanonical role in the post-ischemic heart. Together, these findings make GO:0031013 a high-value term for both mechanistic muscle biology and translational cardiovascular research.
• Defines the inhibitory arm of the troponin complex that gates striated muscle contraction.
• Explains how tropomyosin is held on actin in a low-energy relaxed state.
• Provides the molecular basis for calcium-dependent thin-filament switching.
• Links cardiac troponin I to mitochondrial ATP synthase inhibition after ischemia.
• Underpins antibody and peptide reagents used in myocardial infarction biosensors.
• Supports computational design of troponin I binders with diagnostic potential.
• Enables discrimination between cardiac and skeletal troponin I isoforms.
• Offers a tractable target for CRISPR knockout, point-mutation, and knock-in studies.
• Connects sarcomeric binding chemistry to calmodulin and calcium signaling.
• Provides a framework for studying myosin-driven dissociation of troponin I from actin-tropomyosin.
What Happens During troponin I binding?
Relaxed-state anchoring of tropomyosin
In simple terms: In a relaxed muscle, troponin I acts like a molecular clamp that keeps tropomyosin in place on actin.
In the absence of calcium, troponin I binds tropomyosin and actin in a way that traps tropomyosin on actin in a low-energy relaxed state, blocking myosin access and preventing contraction. This Velcro-like binding by cardiac troponin I is a defining feature of the relaxed thin filament. The interaction is not static; troponin I-induced pivoting of tropomyosin defines thin-filament function in both relaxed and active muscle.
Calcium-dependent switching
In simple terms: When calcium arrives, the troponin complex changes shape and releases the clamp so contraction can proceed.
Calcium binding to troponin C triggers conformational changes that weaken troponin I interactions with actin-tropomyosin, allowing tropomyosin to move and expose myosin-binding sites. Periodic binding of troponin C and troponin I to tropomyosin-actin filaments has been observed, indicating a dynamic equilibrium rather than a simple on-off switch. The free-energy coupling between calcium and troponin I binding to calmodulin further illustrates how calcium and troponin I compete for shared partners.
Myosin-driven dissociation
In simple terms: When myosin heads attach, they help push troponin I off the actin-tropomyosin filament.
Binding of myosin subfragment 1 to actin-tropomyosin dissociates troponin I and the troponin I-troponin C complex from the filament, providing a mechanism for cooperative activation. This dissociation is a key step in the transition from the relaxed to the active state and explains how myosin binding propagates along the thin filament.
Noncanonical mitochondrial binding
In simple terms: Cardiac troponin I can also bind a mitochondrial enzyme and slow energy production after a heart attack.
Cardiac troponin I directly binds and inhibits mitochondrial ATP synthase, revealing a noncanonical role in the post-ischemic heart. This interaction expands the functional repertoire of troponin I binding beyond the sarcomere and links it to mitochondrial energetics.
Key Genes Involved in GO:0031013 troponin I binding
The following genes and proteins are the principal binders, partners, and experimental handles for studying GO:0031013 (troponin I binding).
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNNI3 | Encodes cardiac troponin I, the inhibitory subunit of the cardiac troponin complex | Central to GO:0031013; binds tropomyosin, actin, and mitochondrial ATP synthase |
| TNNI1 | Encodes slow skeletal troponin I | Provides isoform contrast for cardiac versus skeletal troponin I binding studies |
| TNNI2 | Encodes fast skeletal troponin I | Used to dissect isoform-specific binding and regulation |
| TNNT2 | Encodes cardiac troponin T | Part of the troponin complex that coordinates troponin I binding |
| TNNC1 | Encodes cardiac troponin C | Calcium sensor that modulates troponin I binding to actin-tropomyosin |
| TPM1 | Encodes alpha-tropomyosin | Direct binding partner of troponin I on the thin filament |
| ACTA1 | Encodes skeletal alpha-actin | Actin filament component that anchors troponin I-tropomyosin |
| ACTN2 | Encodes alpha-actinin-2 | Sarcomeric structural protein used as a control in binding assays |
| MYH7 | Encodes cardiac myosin heavy chain | Myosin subfragment 1 dissociates troponin I from actin-tropomyosin |
| CALM1 | Encodes calmodulin | Calcium-binding protein that competes with troponin I for binding |
| ATP5F1A | Encodes mitochondrial ATP synthase subunit alpha | Noncanonical binding partner of cardiac troponin I |
| ATP5F1B | Encodes mitochondrial ATP synthase subunit beta | Part of the ATP synthase complex inhibited by cardiac troponin I |
| MYL2 | Encodes myosin regulatory light chain | Modifies myosin activity that influences troponin I dissociation |
| MYL3 | Encodes myosin essential light chain | Structural context for myosin-driven thin-filament activation |
| TNNI3K | Encodes cardiac troponin I-interacting kinase | Kinase that phosphorylates troponin I and modulates binding |
| PRKAA2 | Encodes AMPK catalytic subunit alpha-2 | Metabolic kinase linked to troponin I phosphorylation in ischemia |
| MYBPC3 | Encodes cardiac myosin-binding protein C | Modulates thin-filament activation and troponin I dynamics |
| CALU | Encodes calumenin | Calcium-binding protein used as a control in troponin I interaction studies |
How Is troponin I binding Regulated?
Troponin I binding is regulated by calcium, phosphorylation, and the mechanical state of the sarcomere. Calcium binding to troponin C weakens troponin I interactions with actin-tropomyosin, shifting the thin filament from the relaxed to the active state. Myosin subfragment 1 binding to actin-tropomyosin dissociates troponin I and the troponin I-troponin C complex, providing a cooperative activation mechanism. The free-energy coupling between calcium and troponin I binding to calmodulin shows that calcium directly competes with troponin I for shared partners. In the post-ischemic heart, cardiac troponin I binding to mitochondrial ATP synthase inhibits the enzyme, linking metabolic stress to troponin I regulation.
troponin I binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNNI3 | Myocardial infarction and cardiomyopathy | Knockout and point-mutation cardiomyocytes |
| TNNC1 | Cardiac dysfunction via calcium sensing | Knock-in of calcium-insensitive variants |
| TPM1 | Thin-filament dysregulation | Tropomyosin point-mutation knock-in |
| ATP5F1A | Post-ischemic mitochondrial dysfunction | Cardiac troponin I overexpression in cardiomyocytes |
| MYH7 | Hypertrophic cardiomyopathy | Myosin subfragment 1 binding assays |
Myocardial infarction and cardiac injury
Cardiac troponin I is released into the circulation after myocardial injury and is a gold-standard biomarker of myocardial infarction. Antibody and peptide binders that recognize cardiac troponin I are therefore engineered into biosensors for rapid diagnosis. In the post-ischemic heart, cardiac troponin I binds and inhibits mitochondrial ATP synthase, suggesting a direct role in ischemic mitochondrial dysfunction.
Cardiomyopathy and sarcomeric mutations
Mutations in troponin I and its binding partners alter thin-filament regulation and are associated with cardiomyopathies. Because troponin I binding controls the relaxed state of the thin filament, even subtle changes in this interface can perturb contractility. Computational binding studies help predict how sequence variants affect cardiac versus skeletal troponin I recognition.
Diagnostic biosensor development
The specificity of troponin I binding is exploited in biosensor design, where peptides and antibodies must discriminate cardiac troponin I from skeletal isoforms. Bioinformatics-guided peptide design has been used to create binders for myocardial infarction diagnosis. These reagents depend on the same molecular recognition principles that define GO:0031013.
From troponin I binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of troponin I binding alter relaxed-state thin-filament anchoring? | TNNI3 knockout cardiomyocytes |
| Does a cardiomyopathy mutation change troponin I-tropomyosin affinity? | Point-mutation knock-in of TNNI3 |
| Can a designed peptide discriminate cardiac from skeletal troponin I? | Peptide binding assay with TNNI1/TNNI2 controls |
| Does cardiac troponin I inhibit mitochondrial ATP synthase after ischemia? | TNNI3 overexpression in post-ischemic cardiomyocytes |
| How does calcium compete with troponin I for calmodulin? | Calmodulin binding assay with calcium titration |
| Does myosin subfragment 1 dissociate troponin I from actin-tropomyosin? | In vitro actin-tropomyosin binding assay |
How to Study the troponin I binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro binding assay | Affinity between troponin I and partners | Assigning GO:0031013 to a candidate protein |
| Myosin subfragment 1 dissociation assay | Release of troponin I from actin-tropomyosin | Testing cooperative activation |
| Computational docking | Predicted binding pose and specificity | Cardiac versus skeletal troponin I discrimination |
| Bioinformatics peptide design | Designed binder sequence and affinity | Biosensor development for myocardial infarction |
| Structural analysis | Tropomyosin position on actin | Relaxed versus active thin-filament states |
| Calcium titration | Calcium-dependent binding changes | Calmodulin and troponin C competition |
| CRISPR knockout | Loss-of-function phenotype | Testing requirement for troponin I binding |
| CRISPR knock-in | Mutant protein behavior | Modeling cardiomyopathy variants |
Binding assays
Direct binding assays measure the affinity between troponin I and its partners, including tropomyosin, actin, troponin C, and calmodulin. These assays can be performed with purified proteins or with myosin subfragment 1 to test dissociation. They are the primary method for assigning GO:0031013 to a candidate protein.
Computational docking and design
Computational binding studies model how antibodies and peptides recognize cardiac versus skeletal troponin I. Bioinformatics design pipelines have been used to generate peptide binders for biosensor development. These approaches complement experimental binding data and guide mutagenesis.
Structural and imaging approaches
Structural methods reveal how troponin I induces tropomyosin pivoting and traps it on actin in the relaxed state. Imaging of thin filaments in relaxed and active states shows the positional changes that accompany troponin I binding. These data provide the mechanistic basis for the GO term.
Genetic and CRISPR models
CRISPR knockout, point-mutation, knock-in, and overexpression models test whether specific troponin I residues are required for binding and function. Such models link molecular binding to physiological and disease phenotypes. They are essential for causal inference in troponin I binding research.
How CRISPR Can Be Used to Study GO:0031013 troponin I binding
Knockout
CRISPR knockout of TNNI3 removes cardiac troponin I and abolishes the inhibitory binding that traps tropomyosin on actin in the relaxed state. Such models are used to test whether troponin I binding is required for normal thin-filament regulation. Knockout of partner genes such as TPM1 or TNNC1 provides complementary loss-of-function evidence.
Point Mutation
Point-mutation models introduce specific amino acid changes in troponin I or its partners to test binding interfaces. These models are ideal for dissecting cardiomyopathy-associated variants that alter troponin I-tropomyosin affinity. They also help validate computational predictions of cardiac versus skeletal troponin I specificity.
Knock-in
Knock-in of tagged or mutant troponin I allows tracking of binding dynamics in living cells. Tagged knock-in lines can be used to measure troponin I localization to the sarcomere or to mitochondria. Knock-in of disease variants provides a physiologically relevant context for GO:0031013 studies.
Overexpression
Overexpression of cardiac troponin I is used to test noncanonical binding to mitochondrial ATP synthase in the post-ischemic heart. Overexpression can also saturate binding partners and reveal dose-dependent effects on thin-filament regulation. These models complement knockout and knock-in approaches for causal inference.
How EDITGENE Supports troponin I binding Research
Researchers studying troponin I binding-related genes often need to determine whether a candidate gene is causally involved in thin-filament regulation, mitochondrial crosstalk, or disease phenotypes. EDITGENE provides the full suite of CRISPR cell models and screening services required to move from correlation to causation for GO:0031013.
Contact EDITGENE today to design your custom CRISPR model for troponin I binding research.
Frequently Asked Questions About troponin I binding
What is GO:0031013 troponin I binding?
GO:0031013 is a molecular function defined as binding to troponin I, the inhibitory subunit of the troponin complex.
What genes are involved in troponin I binding?
Key genes include TNNI3, TNNI1, TNNI2, TNNT2, TNNC1, TPM1, ACTA1, and ATP5F1A.
Why is troponin I binding important for muscle contraction?
It traps tropomyosin on actin in a low-energy relaxed state and is released in a calcium-dependent manner to allow contraction.
Does cardiac troponin I bind mitochondrial ATP synthase?
Yes, cardiac troponin I directly binds and inhibits mitochondrial ATP synthase in the post-ischemic heart.
How is troponin I binding studied experimentally?
It is studied with binding assays, computational docking, structural analysis, and CRISPR genetic models.
What diseases are linked to troponin I binding?
Myocardial infarction, cardiomyopathy, and post-ischemic mitochondrial dysfunction are linked to troponin I binding.
Can troponin I binding be used for diagnostics?
Yes, antibody and peptide binders to cardiac troponin I are used in biosensors for myocardial infarction diagnosis.
What is the difference between cardiac and skeletal troponin I binding?
Cardiac and skeletal troponin I isoforms differ in sequence and are discriminated by computational and antibody binding studies.
How does calcium regulate troponin I binding?
Calcium binding to troponin C weakens troponin I interactions with actin-tropomyosin and shifts the thin filament to the active state.
What CRISPR models are available for troponin I binding research?
Knockout, point-mutation, knock-in, and overexpression models are available to test causal roles of troponin I binding.
Conclusion
GO:0031013 (troponin I binding) is a molecular function at the heart of striated muscle regulation, where troponin I anchors tropomyosin on actin in the relaxed state and releases it upon calcium signaling. Beyond the sarcomere, cardiac troponin I binds mitochondrial ATP synthase, linking this function to post-ischemic energetics. The interaction is also a validated diagnostic target, with engineered binders enabling myocardial infarction biosensors. CRISPR knockout, point-mutation, knock-in, and overexpression models now make it possible to test the causal contribution of each binding interface to physiology and disease.
References
- 1. Ramachandran B et al.. 2025. Velcro-binding by cardiac troponin-I traps tropomyosin on actin in a low-energy relaxed state.. Biochem Biophys Res Commun 757:151595 PMID: 40088678
- 2. Elezaby A et al.. 2024. Cardiac troponin I directly binds and inhibits mitochondrial ATP synthase with a noncanonical role in the post-ischemic heart.. Nat Cardiovasc Res 3(8):987-1002 PMID: 39196031
- 3. Lehman W et al.. 2023. Troponin-I-induced tropomyosin pivoting defines thin-filament function in relaxed and active muscle.. J Gen Physiol 155(7) PMID: 37249525
- 4. Sabek J et al.. 2019. Computational binding study of cardiac troponin I antibody towards cardiac versus skeletal troponin I.. Comput Biol Chem 80:147-151 PMID: 30959270
- 5. Keller CH et al.. 1982. Determination of the free-energy coupling for binding of calcium ions and troponin I to calmodulin.. Biochemistry 21(1):156-62 PMID: 7059575
- 6. Zhou X et al.. 2000. Binding of troponin I and the troponin I-troponin C complex to actin-tropomyosin. Dissociation by myosin subfragment 1.. Biochemistry 39(5):1128-32 PMID: 10653659
- 7. Jauhar MM et al.. 2024. Bioinformatics design of peptide binding to the human cardiac troponin I (cTnI) in biosensor development for myocardial infarction diagnosis.. PLoS One 19(10):e0305770 PMID: 39436888
- 8. Ohtsuki I et al.. 2002. Periodic binding of troponin C.I and troponin I to tropomyosin-actin filaments.. J Biochem 131(5):739-43 PMID: 11983082
